Skip to main content

Imaging Modalities

  • Chapter
Benign Tumors of the Liver

Abstract

Benign focal liver lesions, including cysts, hemangiomas, and focal nodular hyperplasia, are common. Annually, many patients worldwide undergo imaging for the work-up of a suspected or known abnormality of the liver. Cross-sectional imaging modalities, such as US, CT, and MR imaging, are used in most centers to assess liver abnormalities. These modalities, often used in various combinations, have fundamental differences in data acquisition and hence differences in the type of physical characteristics of tissues they interrogate. Currently, there is no consensus concerning the optimal strategy for liver imaging. Imaging modalities are often used based on the requests of referring physicians and the availability of equipment and experience of the radiologists. Most centers use US, CT, and CT-guided biopsy; MR imaging is often used as a problem-solving modality. The main goals of imaging are to assess (1) the nature of the lesions, (2) the number and size of liver abnormalities, and (3) the location of abnormalities relative to the vessels. All these aspects influence clinical and surgical decision making. This chapter describes a number of aspects of liver imaging including the current status and recent development of ultrasound, CT, and MR imaging and the role of these imaging modalities in the assessment of benign hepatic abnormalities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Karhunen PJ (1986) Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 39(2):183–188

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Ishak KG, Rabin L (1975) Benign tumors of the liver. Med Clin North Am 59(4):995–1013

    CAS  PubMed  Google Scholar 

  3. Valette PJ, Pilleul F, Crombe-Ternamian A (2003) MDCT of benign liver tumors and metastases. Eur Radiol 13(Suppl 5):M31–M41

    Article  PubMed  Google Scholar 

  4. Harvey CJ, Albrecht T (2001) Ultrasound of focal liver lesions. Eur Radiol 11(9):1578–1593

    Article  CAS  PubMed  Google Scholar 

  5. McNaughton DA, Abu-Yousef MM (2011) Doppler US of the liver made simple. Radiographics 31(1):161–188. doi:10.1148/rg.311105093

    Article  PubMed  Google Scholar 

  6. Shapiro RS, Wagreich J, Parsons RB, Stancato-Pasik A, Yeh HC, Lao R (1998) Tissue harmonic imaging sonography: evaluation of image quality compared with conventional sonography. AJR Am J Roentgenol 171(5):1203–1206. doi:10.2214/ajr.171.5.9798848

    Article  CAS  PubMed  Google Scholar 

  7. Hann LE, Bach AM, Cramer LD, Siegel D, Yoo HH, Garcia R (1999) Hepatic sonography: comparison of tissue harmonic and standard sonography techniques. AJR Am J Roentgenol 173(1):201–206. doi:10.2214/ajr.173.1.10397127

    Article  CAS  PubMed  Google Scholar 

  8. Tchelepi H, Ralls PW (2004) Ultrasound of focal liver masses. Ultrasound Q 20(4):155–169

    Article  PubMed  Google Scholar 

  9. Bolondi L, Correas JM, Lencioni R, Weskott HP, Piscaglia F (2007) New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice. Dig Liver Dis 39(2):187–195. doi:10.1016/j.dld.2006.08.008

    Article  CAS  PubMed  Google Scholar 

  10. Sutherland T, Temple F, Lee WK, Hennessy O (2011) Evaluation of focal hepatic lesions with ultrasound contrast agents. J Clin Ultrasound 39(7):399–407. doi:10.1002/jcu.20847

    Article  PubMed  Google Scholar 

  11. Bartolotta TV, Taibbi A, Midiri M, Lagalla R (2009) Focal liver lesions: contrast-enhanced ultrasound. Abdom Imaging 34(2):193–209. doi:10.1007/s00261-008-9378-6

    Article  PubMed  Google Scholar 

  12. Quaia E, Calliada F, Bertolotto M, Rossi S, Garioni L, Rosa L et al (2004) Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 232(2):420–430. doi:10.1148/radiol.2322031401

    Article  PubMed  Google Scholar 

  13. Solbiati L, Tonolini M, Cova L, Goldberg SN (2001) The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol 11(Suppl 3):E15–E26. doi:10.1007/s003300100003

    Article  PubMed  Google Scholar 

  14. Catala V, Nicolau C, Vilana R, Pages M, Bianchi L, Sanchez M et al (2007) Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography. Eur Radiol 17(4):1066–1073. doi:10.1007/s00330-006-0444-6

    Article  CAS  PubMed  Google Scholar 

  15. Li R, Guo Y, Hua X, He Y, Ding J, Guo A et al (2007) Characterization of focal liver lesions: comparison of pulse-inversion harmonic contrast-enhanced sonography with contrast-enhanced CT. J Clin Ultrasound 35(3):109–117. doi:10.1002/jcu.20310

    Article  PubMed  Google Scholar 

  16. Quaia E, D’Onofrio M, Palumbo A, Rossi S, Bruni S, Cova M (2006) Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol 16(7):1599–1609. doi:10.1007/s00330-006-0192-7

    Article  PubMed  Google Scholar 

  17. Larsen LP, Rosenkilde M, Christensen H, Bang N, Bolvig L, Christiansen T et al (2007) The value of contrast enhanced ultrasonography in detection of liver metastases from colorectal cancer: a prospective double-blinded study. Eur J Radiol 62(2):302–307. doi:10.1016/j.ejrad.2006.11.033

    Article  PubMed  Google Scholar 

  18. Kopp AF, Heuschmid M, Claussen CD (2002) Multidetector helical CT of the liver for tumor detection and characterization. Eur Radiol 12(4):745–752. doi:10.1007/s00330-001-1177-1

    Article  PubMed  Google Scholar 

  19. Brancatelli G, Federle MP, Katyal S, Kapoor V (2002) Hemodynamic characterization of focal nodular hyperplasia using three-dimensional volume-rendered multidetector CT angiography. AJR Am J Roentgenol 179(1):81–85. doi:10.2214/ajr.179.1.1790081

    Article  PubMed  Google Scholar 

  20. Kamel IR, Georgiades C, Fishman EK (2003) Incremental value of advanced image processing of multislice computed tomography data in the evaluation of hypervascular liver lesions. J Comput Assist Tomogr 27(4):652–656

    Article  PubMed  Google Scholar 

  21. Kamel IR, Lawler LP, Fishman EK (2004) Comprehensive analysis of hypervascular liver lesions using 16-MDCT and advanced image processing. AJR Am J Roentgenol 183(2):443–452. doi:10.2214/ajr.183.2.1830443

    Article  PubMed  Google Scholar 

  22. Sahani D, Saini S, Pena C, Nichols S, Prasad SR, Hahn PF et al (2002) Using multidetector CT for preoperative vascular evaluation of liver neoplasms: technique and results. AJR Am J Roentgenol 179(1):53–59. doi:10.2214/ajr.179.1.1790053

    Article  PubMed  Google Scholar 

  23. Foley WD, Mallisee TA, Hohenwalter MD, Wilson CR, Quiroz FA, Taylor AJ (2000) Multiphase hepatic CT with a multirow detector CT scanner. AJR Am J Roentgenol 175(3):679–685. doi:10.2214/ajr.175.3.1750679

    Article  CAS  PubMed  Google Scholar 

  24. Paulson EK, McDermott VG, Keogan MT, DeLong DM, Frederick MG, Nelson RC (1998) Carcinoid metastases to the liver: role of triple-phase helical CT. Radiology 206(1):143–150. doi:10.1148/radiology.206.1.9423664

    Article  CAS  PubMed  Google Scholar 

  25. Frederick MG, Paulson EK, Nelson RC (1997) Helical CT for detecting focal liver lesions in patients with breast carcinoma: comparison of noncontrast phase, hepatic arterial phase, and portal venous phase. J Comput Assist Tomogr 21(2):229–235

    Article  CAS  PubMed  Google Scholar 

  26. Sheafor DH, Frederick MG, Paulson EK, Keogan MT, DeLong DM, Nelson RC (1999) Comparison of unenhanced, hepatic arterial-dominant, and portal venous-dominant phase helical CT for the detection of liver metastases in women with breast carcinoma. AJR Am J Roentgenol 172(4):961–968. doi:10.2214/ajr.172.4.10587129

    Article  CAS  PubMed  Google Scholar 

  27. Leifer DM, Middleton WD, Teefey SA, Menias CO, Leahy JR (2000) Follow-up of patients at low risk for hepatic malignancy with a characteristic hemangioma at US. Radiology 214(1):167–172. doi:10.1148/radiology.214.1.r00ja09167

    Article  CAS  PubMed  Google Scholar 

  28. Vilgrain V, Boulos L, Vullierme MP, Denys A, Terris B, Menu Y (2000) Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics 20(2):379–397. doi:10.1148/radiographics.20.2.g00mc01379

    Article  CAS  PubMed  Google Scholar 

  29. Kim T, Federle MP, Baron RL, Peterson MS, Kawamori Y (2001) Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT. Radiology 219(3):699–706. doi:10.1148/radiology.219.3.r01jn45699

    Article  CAS  PubMed  Google Scholar 

  30. Semelka RC, Martin DR, Balci C, Lance T (2001) Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 13(3):397–401

    Article  CAS  PubMed  Google Scholar 

  31. Miller FH, Hammond N, Siddiqi AJ, Shroff S, Khatri G, Wang Y et al (2010) Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions. J Magn Reson Imaging 32(1):138–147. doi:10.1002/jmri.22235

    Article  PubMed  Google Scholar 

  32. Bhargava P, Vaidya S, Kolokythas O, Katz DS, Dighe M (2011) Hepatic vascular shunts: embryology and imaging appearances. Br J Radiol 84(1008):1142–1152. doi:10.1259/bjr/82649468

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  33. Semelka RC, Helmberger TK (2001) Contrast agents for MR imaging of the liver. Radiology 218(1):27–38. doi:10.1148/radiology.218.1.r01ja2427

    Article  CAS  PubMed  Google Scholar 

  34. Petersein J, Spinazzi A, Giovagnoni A, Soyer P, Terrier F, Lencioni R et al (2000) Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging–a multicenter phase III clinical study. Radiology 215(3):727–736. doi:10.1148/radiology.215.3.r00jn14727

    Article  CAS  PubMed  Google Scholar 

  35. Filippone A, Blakeborough A, Breuer J, Grazioli L, Gschwend S, Hammerstingl R et al (2010) Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine. J Magn Reson Imaging 31(2):356–364. doi:10.1002/jmri.22054

    Article  PubMed  Google Scholar 

  36. Goodwin MD, Dobson JE, Sirlin CB, Lim BG, Stella DL (2011) Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents. Radiographics 31(6):1547–1568. doi:10.1148/rg.316115528

    Article  PubMed  Google Scholar 

  37. Klein D, Jenett M, Gassel HJ, Sandstede J, Hahn D (2004) Quantitative dynamic contrast-enhanced sonography of hepatic tumors. Eur Radiol 14(6):1082–1091. doi:10.1007/s00330-004-2299-z

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesco De Cobelli .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing AG Switzerland

About this chapter

Cite this chapter

De Cobelli, F., Ironi, G., Marra, P., Esposito, A., Del Maschio, A. (2015). Imaging Modalities. In: Aldrighetti, L., Cetta, F., Ferla, G. (eds) Benign Tumors of the Liver. Springer, Cham. https://doi.org/10.1007/978-3-319-12985-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-12985-3_5

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-12984-6

  • Online ISBN: 978-3-319-12985-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics